BROMOCRIPTINE AND PSYCHOSIS - A LITERATURE-REVIEW

Bromocriptin is an ergot-derived dopamine agonist. Its current uses in clude the treatment of Parkinson's disease, postpartum ablaction, prol actinomas, acromegaly, and amenorrhea and galactorrhea secondary to ne uroleptic use. It is often reported to produce psychiatric side effect s such as confusion, hallucinations, and delusions. The literature is reviewed and supports a strong anecdotal relationship between bromocri ptine use and psychosis.